Samatasvir
Samatasvir is a pan-genotypic small molecule inhibitor targeting the hepatitis C virus (HCV) non-structural protein 5A (NS5A) . It is utilized in antiviral research for studying HCV replication mechanisms and has been evaluated in both in vitro assays and clinical (in vivo) trials for combination therapies.
Product Specifications
CAS Number
1312547-19-5
Product Name Alternative
Samatasvir, replication, IDX719, IDX-719, IDX18719, IDX-18719, IDX 18719, IDX 719, Inhibitor, HCV Protease, HCVProtease, HCV, Hepatitis C virus, inhibit, infectious, NS5A, ATOLIHZIXHZSBA-BTSKBWHGSA-N, antiviral agent
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Purity
98.03% (May vary between batches)
Solubility
DMSO:50 mg/mL (56.49 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.26 mM)
Smiles
COC (=O) N[C@@H] (C (C) C) C (=O) N1CCC[C@H]1c1nc2ccc (cc2[nH]1) -c1csc2c (csc12) -c1ccc (cc1) -c1cnc ([nH]1) [C@@H]1CCCN1C (=O) [C@H] (NC (=O) OC) c1ccccc1
Molecular Formula
C47H48N8O6S2
Molecular Weight
885.06
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
